Telemonitoring in heart failure
- Conditions
- Congestive heart failureCirculatory SystemHeart failure
- Registration Number
- ISRCTN39223875
- Lead Sponsor
- Heart Centre Hasselt vzw (Belgium)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 160
1. Patients hospitalised for decompensated heart failure, necessitating intravenous (IV) diuretics or augmentation of oral (PO) diuretic, IV inotropic or IV vasodilator. Patients should be stabilised with treatment including angiotensin converting enzyme (ACE) inhibitors (or angiotensin II receptor antagonists [AIIA]), betablockers and diuretics at discharge.
2. Patients should be capable of understanding the aims of the study and to use the telemonitoring system
3. Aged between 50 and 85 years, either sex
1. Reversible forms of heart failure
2. Heart failure due to aortic stenosis
3. Isolated right heart failure
4. Patients residing in elderly homes
5. Severe renal disease (glomerular filtration rate [GFR] less than 20 ml/min), planned dialysis in the next 6 months
6. Planned implantation of biventricular pacemaker, or cardiac surgery
7. Life expectancy less than 1 year
8. Severe pulmonary disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Number and duration of hospitalisation after the start of the study<br>2. Number of unplanned consultations with the heart failure team and GP<br>3. Number of phone calls (and amount of time spent) between the HF nurse and the patient<br>4. Quality of life (Minnesota Living with Heart Failure Questionnaire)<br>5. Mortality rate<br>6. Number of medication changes<br>7. Number of changes in alert limits<br><br>Measured at entry of study, and after 6 months of follow-up.
- Secondary Outcome Measures
Name Time Method Blood B-type natriuretic peptide (BNP) content, measured at entry of study, and after 6 months of follow-up.